Publications by authors named "Cathy Critchlow"

Claim this Profile
A
A Multi-Country Study of the Clinical Course of Extensive-Stage Small Cell Lung Cancer: A Six-Study Analysis of Real-World Treatment Patterns and Outcomes.
Xerxes Pundole, Diana Younan, Cathy W Critchlow, Stephen R Puntis, Melissa Soohoo

Clin Epidemiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence.
Rohini K Hernandez, Cathy W Critchlow, Nancy Dreyer, Timothy L Lash, Robert F Reynolds

Clin Pharmacol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative review.
Sara N Levintow, Carrie M Nielson, Rohini K Hernandez, Alexander Breskin, David Pritchard, Cathy Critchlow

Pharmacoepidemiol Drug Saf· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort study.
John H Page, Ajit A Londhe, Corinne Brooks, Jie Zhang, J Michael Sprafka, Cathy W Critchlow

BMJ Open· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Case Study of the Use of Real-World Evidence to Support the Registration of an Osteoporosis Product in China.
Neal E Storm, Wen Chang, Tzu-Chieh Lin, Jeff L Lange, Brian Bradbury, Cathy W Critchlow

Ther Innov Regul Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning applications for therapeutic tasks with genomics data.
Kexin Huang, Cao Xiao, Lucas M Glass, Cathy W Critchlow, Greg Gibson

Patterns (N Y)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of hospitalised adults with COVID-19 in a Global Health Research Network: a cohort study.
Julia Zhu, Zhongyuan Wei, Manasi Suryavanshi, Xiu Chen, Qian Xia, Cathy W Critchlow

BMJ Open· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence to support regulatory decision making: New or expanded medical product indications.
Jessica M Franklin, Kai-Li Liaw, Solomon Iyasu, Cathy W Critchlow, Nancy A Dreyer

Pharmacoepidemiol Drug Saf· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms.
Mehmet Burcu, Nancy A Dreyer, Jessica M Franklin, Michael D Blum, Cathy W Critchlow

Pharmacoepidemiol Drug Saf· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive values of diagnostic codes for identifying serious hypocalcemia and dermatologic adverse events among women with postmenopausal osteoporosis in a commercial health plan database.
Florence T Wang, Fei Xue, Yan Ding, Eva Ng, Cathy W Critchlow

BMC Health Serv Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes.
Prasad L Gawade, Jesse A Berlin, David H Henry, Dianne Tomita, Barry D Brooks, Cathy W Critchlow

Pharmacoepidemiol Drug Saf· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of persistence with bisphosphonates on health resource utilization and fracture risk in the UK: a study of patient records from the UK Clinical Practice Research Datalink.
Samara Ferguson, Maurille Feudjo Tepie, Andrew Taylor, Andrew Roddam, Cathy Critchlow

J Eval Clin Pract· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and evaluation of an algorithm to identify users of Prolia(®) during the early postmarketing period using health insurance claims data.
Veena Hoffman, Fei Xue, Betsey Gardstein, Kathleen Skerry, Cathy W Critchlow

Pharmacoepidemiol Drug Saf· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing patterns of use of osteoporosis medications in the years after launch: implications for comparative effectiveness research.
B Diane Reams, Cynthia D O'Malley, Cathy W Critchlow, Julie C Lauffenburger, M Alan Brookhart

Pharmacoepidemiol Drug Saf· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women.
Akhila Balasubramanian, M Alan Brookhart, Vamshidar Goli, Cathy W Critchlow

Int J Gen Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis.
Fei Xue, Haijun Ma, Catherine Stehman-Breen, Christine Haller, Leonid Katz, Cathy W Critchlow

Pharmacoepidemiol Drug Saf· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Completeness of prescription information in US commercial claims databases.
Julie C Lauffenburger, Akhila Balasubramanian, Joel F Farley, Cathy W Critchlow, Cynthia D O'Malley

Pharmacoepidemiol Drug Saf· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Danish National Registry of Patients.
Henrik Gammelager, Claus Sværke, Sven Erik Noerholt, Bjarne Neumann-Jensen, Fei Xue, Cathy Critchlow

Clin Epidemiol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of ICD-9 codes to identify nonunion and malunion and developing algorithms to improve case-finding of nonunion and malunion.
Denise M Boudreau, Onchee Yu, Leslie Spangler, Thy P Do, Monica Fujii, Cathy W Critchlow

Bone· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database.
Rohini K Hernandez, Thy P Do, Cathy W Critchlow, Ricardo E Dent, Susan S Jick

Acta Orthop· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV shedding in the oral cavity: an assessment of HIV type, immunovirologic, demographic and oral factors.
Patricia B Pavlinac, Stephen E Hawes, Geoffrey S Gottlieb, Awa Gaye, Charlotte F N'Diaye, Cathy W Critchlow

Sex Transm Infect· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between epoetin alfa dose and mortality: findings from a marginal structural model.
Ouhong Wang, Ryan D Kilpatrick, Cathy W Critchlow, Xiang Ling, Brian D Bradbury

Clin J Am Soc Nephrol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL.
Brian D Bradbury, Thy P Do, Wolfgang C Winkelmayer, Cathy W Critchlow, M Alan Brookhart

Pharmacoepidemiol Drug Saf· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations.
Brian D Bradbury, M Alan Brookhart, Wolfgang C Winkelmayer, Cathy W Critchlow, Ryan D Kilpatrick

Am J Kidney Dis· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Epoetin alfa dose changes on hemoglobin and mortality in hemodialysis patients with hemoglobin levels persistently below 11 g/dL.
Brian D Bradbury, Mark D Danese, Michelle Gleeson, Cathy W Critchlow

Clin J Am Soc Nephrol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis